The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
DC-based cancer vaccines
Open accessAbstract
Because of the large preexisting antigenic load and immunosuppressive environment within a tumor, inducing therapeutically useful antitumor immunity in cancer patients requires the development of powerful vaccination protocols. An approach gaining increasing popularity in the tumor vaccine field is to immunize cancer patients with their own DCs loaded ex vivo with tumor antigens. The underlying premise of this approach is that the efficiency and control over the vaccination process provided by ex vivo manipulation of the DCs generates an optimally potent APC and a superior method for stimulating antitumor immunity in vivo compared with the more conventional direct vaccination methods, offsetting the added cost and complexity associated with this form of customized cell therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Immunobiology of Dendritic Cells
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.-J., Pulendran, B., & Palucka, K. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.767 · Cited by 6,634
Exosomes: composition, biogenesis and function
Théry, C., Zitvogel, L., & Amigorena, S. (2002) · Nature Reviews Immunology · doi:10.1038/nri855 · Cited by 5,346
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,193
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., & Steinman, R. M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1693 · Cited by 3,738
Nasir, O. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000350152 · Cited by 2,331
Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., Ricciardi-Castagnoli, P., Raposo, G., & Amigorena, S. (1998) · Nature Medicine · doi:10.1038/nm0598-594 · Cited by 2,266
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
Grewal, I. S., & Flavell, R. A. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.111 · Cited by 1,539
TNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL RESPONSES
Watts, T. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115839 · Cited by 1,353
Cancer despite immunosurveillance: immunoselection and immunosubversion
Zitvogel, L., Tesniere, A., & Kroemer, G. (2006) · Nature reviews. Immunology · doi:10.1038/nri1936 · Cited by 1,324
Dendritic cells as therapeutic vaccines against cancer
Banchereau, J., & Palucka, A. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1592 · Cited by 1,204
Jonuleit, H., Kühn, U., Müller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Knop, J., & Enk, A. H. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271209 · Cited by 1,163
Napolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F., & Lanzavecchia, A. (2005) · Nature Immunology · doi:10.1038/ni1223 · Cited by 1,157
Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells
Langenkamp, A., Messi, M., Lanzavecchia, A., & Sallusto, F. (2000) · Nature Immunology · doi:10.1038/79758 · Cited by 1,143
Dendritic-cell trafficking to lymph nodes through lymphatic vessels
Randolph, G. J., Angeli, V., & Swartz, M. A. (2005) · Nature Reviews Immunology · doi:10.1038/nri1670 · Cited by 1,111
Dannull, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25947 · Cited by 989
Regulation of Dendritic Cell Migration to the Draining Lymph Node
Martín-Fontecha, A., Sebastiani, S., Höpken, U. E., Uguccioni, M., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030448 · Cited by 878
Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?
Croft, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1148 · Cited by 863
Professional Antigen-Presentation Function by Human γδ T Cells
Brandes, M., Willimann, K., & Moser, B. (2005) · Science · doi:10.1126/science.1110267 · Cited by 751
The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review
Schönbeck*RID="*"ID="*" Correspondi, U., & Libby, P. (2001) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000776 · Cited by 737
The use of dendritic cells in cancer immunotherapy
Schuler, G., Schuler-Thurner, B., & Steinman, R. M. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00015-3 · Cited by 631
Spörri, R., & Reis e Sousa, C. (2005) · Nature Immunology · doi:10.1038/ni1162 · Cited by 626
Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
Gavin, A. L., Hoebe, K., Duong, B., Ota, T., Martin, C., Beutler, B., & Nemazee, D. (2006) · Science · doi:10.1126/science.1135299 · Cited by 581
Checkpoint Blockade in Cancer Immunotherapy
Korman, A. J., Peggs, K. S., & Allison, J. P. (2006) · Advances in Immunology · doi:10.1016/s0065-2776(06)90008-x · Cited by 570
Heiser, A., Coleman, D., Dannull, J., Yancey, D., Maurice, M. A., Lallas, C. D., Dahm, P., Niedzwiecki, D., Gilboa, E., & Vieweg, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214364 · Cited by 562
Self-citationGautier, G., Humbert, M., Deauvieau, F., Scuiller, M., Hiscott, J., Bates, E. E. M., Trinchieri, G., Caux, C., & Garrone, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041964 · Cited by 537
Alexander-Miller, M. A., Leggatt, G. R., & Berzofsky, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4102 · Cited by 501
Scandella, E., Men, Y., Gillessen, S., Förster, R., & Groettrup, M. (2002) · Blood · doi:10.1182/blood-2001-11-0017 · Cited by 500
(2003) · PubMed · Cited by 477
α-Type-1 Polarized Dendritic Cells
Mailliard, R. B., Wankowicz-Kalinska, A., Cai, Q., Wesa, A., Hilkens, C. M., Kapsenberg, M. L., Kirkwood, J. M., Storkus, W. J., & Kalinski, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1261 · Cited by 470
Van Tendeloo, V. F. I., Ponsaerts, P., Lardon, F., Nijs, G., Lenjou, M., Van Broeckhoven, C., Van Bockstaele, D. R., & Berneman, Z. N. (2001) · Blood · doi:10.1182/blood.v98.1.49 · Cited by 468
Schadendorf, D., Ugurel, S., Schuler-Thurner, B., Nestle, F. O., Enk, A., Bröcker, E.-B., Grabbe, S., Rittgen, W., Edler, L., Sucker, A., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj138 · Cited by 467
Therapeutic dendritic-cell vaccine for chronic HIV-1 infection
Lu, W., Arraes, L. C., Ferreira, W. T., & Andrieu, J.-M. (2004) · Nature Medicine · doi:10.1038/nm1147 · Cited by 448
Nair, S. K., Boczkowski, D., Morse, M., Cumming, R. I., Lyerly, H. K., & Gilboa, E. (1998) · Nature Biotechnology · doi:10.1038/nbt0498-364 · Cited by 398
Self-citationThe Makings of a Tumor Rejection Antigen
Gilboa, E. (1999) · Immunity · doi:10.1016/s1074-7613(00)80101-6 · Cited by 381
Self-citationHigh Avidity CTLs for Two Self-Antigens Demonstrate Superior In Vitro and In Vivo Antitumor Efficacy
Zeh, H. J., Perry-Lalley, D., Dudley, M. E., Rosenberg, S. A., & Yang, J. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.989 · Cited by 376
Su, Z. Z., Dannull, J., Heiser, A., Yancey, D. R., Pruitt, S. K., Madden, J., Coleman, D., Niedzwiecki, D., Gilboa, E., & Vieweg, J. (2003) · PubMed · Cited by 366
Self-citationLanzavecchia, A. (1998) · Nature · doi:10.1038/30845 · Cited by 360
Su, Z., Dannull, J., Yang, B. K., Dahm, P., Coleman, D., Yancey, D., Sichi, S., Niedzwiecki, D., Boczkowski, D., Gilboa, E., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3798 · Cited by 359
Self-citationLuft, T., Jefford, M., Luetjens, P., Toy, T., Hochrein, H., Masterman, K.-A., Maliszewski, C., Shortman, K., Cebon, J., & Maraskovsky, E. (2002) · Blood · doi:10.1182/blood-2001-12-0360 · Cited by 358
Nair, S. K., Heiser, A., Boczkowski, D., Majumdar, A., Naoe, M., Lebkowski, J. S., Vieweg, J., & Gilboa, E. (2000) · Nature Medicine · doi:10.1038/79519 · Cited by 348
Self-citationWu, T. C., Guarnieri, F. G., Staveley-O'Carroll, K. F., Viscidi, R. P., Levitsky, H. I., Hedrick, L., Cho, K. R., August, J. T., & Pardoll, D. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11671 · Cited by 344
Manipulating dendritic cell biology for the active immunotherapy of cancer
O'Neill, D. W., Adams, S., & Bhardwaj, N. (2004) · Blood · doi:10.1182/blood-2003-12-4392 · Cited by 339
Dauer, M., Obermaier, B., Herten, J., Haerle, C., Pohl, K., Rothenfusser, S., Schnurr, M., Endres, S., & Eigler, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4069 · Cited by 319
Dendritic Cells as Sensors of Infection
e Sousa, C. R. (2001) · Immunity · doi:10.1016/s1074-7613(01)00136-4 · Cited by 319
Cancer immunotherapy with mRNA‐transfected dendritic cells
Gilboa, E., & Vieweg, J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00139.x · Cited by 316
Self-citationStimulation History Dictates Memory CD8 T Cell Phenotype: Implications for Prime-Boost Vaccination
Masopust, D., Ha, S.-J., Vezys, V., & Ahmed, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.831 · Cited by 315
Banerjee, D. K., Dhodapkar, M. V., Matayeva, E., Steinman, R. M., & Dhodapkar, K. M. (2006) · Blood · doi:10.1182/blood-2006-03-011353 · Cited by 311
On regulation of phagosome maturation and antigen presentation
Blander, J. M., & Medzhitov, R. (2006) · Nature Immunology · doi:10.1038/ni1006-1029 · Cited by 310
Yewdell, J. W., Norbury, C. C., & Bennink, J. R. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60785-3 · Cited by 284
The promise of cancer vaccines
Gilboa, E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1359 · Cited by 267
Self-citationShen, L., Evel-Kabler, K., Strube, R., & Chen, S.-Y. (2004) · Nature Biotechnology · doi:10.1038/nbt1035 · Cited by 267
The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity
Wang, R.-F. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01896-8 · Cited by 266
Czerniecki, B. J., Koski, G. K., Koldovsky, U., Xu, S., Cohen, P. A., Mick, R., Nisenbaum, H., Pasha, T., Xu, M., Fox, K. R., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4038 · Cited by 266
Rees, W., Bender, J., Teague, T. K., Kedl, R. M., Crawford, F., Marrack, P., & Kappler, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9781 · Cited by 262
Pozzi, L.-A. M., Maciaszek, J. W., & Rock, K. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2071 · Cited by 259
Kaliński, P., Schuitemaker, J. H. N., Hilkens, C. M. U., et al. (1999) · PubMed · Cited by 257
Schmitz, M., Diestelkoetter, P., Weigle, B., Schmachtenberg, F., Stevanović, S., Ockert, D., Rammensee, H., & Rieber, E. P. (2000) · PubMed · Cited by 243
Warger, T., Osterloh, P., Rechtsteiner, G., Fassbender, M., Heib, V., Schmid, B., Schmitt, E., Schild, H., & Radsak, M. P. (2006) · Blood · doi:10.1182/blood-2005-10-4015 · Cited by 242
Therapeutic dendritic-cell vaccine for simian AIDS
Lu, W., Wu, X., Lu, Y., Guo, W., & Andrieu, J.-M. (2003) · Nature Medicine · doi:10.1038/nm806 · Cited by 238
Alexander-Miller, M. A., Leggatt, G. R., Sarin, A., & Berzofsky, J. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.485 · Cited by 222
The DRiP hypothesis decennial: support, controversy, refinement and extension
Yewdell, J. W., & Nicchitta, C. V. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.06.008 · Cited by 218
Kaliński, P., Schuitemaker, J. H. N., Hilkens, C. M. U., Wierenga, E. A., & Kapsenberg, M. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3231 · Cited by 211
Medema, J. P., Schuurhuis, D. H., Rea, D., van Tongeren, J., de Jong, J., Bres, S. A., Laban, S., Toes, R. E. M., Toebes, M., Schumacher, T. N. M., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.657 · Cited by 207
Dendritic-cell-based therapeutic vaccination against cancer
Nestle, F. O., Farkas, A., & Conrad, C. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.02.003 · Cited by 199
Reis e Sousa, C., Yap, G., Schulz, O., Rogers, N., Schito, M., Aliberti, J., Hieny, S., & Sher, A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80138-7 · Cited by 196
Heiser, A., Dahm, P., R. Yancey, D., Maurice, M. A., Boczkowski, D., Nair, S. K., Gilboa, E., & Vieweg, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5508 · Cited by 187
Self-citationWille-Reece, U., Wu, C.-Y., Flynn, B. J., Kedl, R. M., & Seder, R. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7676 · Cited by 185
Viral vectors for dendritic cell-based immunotherapy
Jenne, L., Schuler, G., & Steinkasserer, A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(00)01813-5 · Cited by 180
Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins
Kim, T. W., Hung, C., Ling, M. F., Juang, J., He, L., Hardwick, J. M., Kumar, S., & Wu, T. ‐. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17293 · Cited by 179
Wilson, N. S., & Villadangos, J. A. (2005) · Advances in Immunology · doi:10.1016/s0065-2776(04)86007-3 · Cited by 176
Cohen, N., Mouly, E., Hamdi, H., Maillot, M.-C., Pallardy, M., Godot, V., Capel, F., Balian, A., Naveau, S., Galanaud, P., et al. (2006) · Blood · doi:10.1182/blood-2005-07-2760 · Cited by 170
He, Y., Zhang, J., Mi, Z., Robbins, P. D., & Falo, L. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3808 · Cited by 164
Nair, S., McLaughlin, C., Weizer, A., Su, Z., Boczkowski, D., Dannull, J., Vieweg, J., & Gilboa, E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6275 · Cited by 164
Self-citationNegative Selection during the Peripheral Immune Response to Antigen
Anderton, S. M., Radu, C. G., Lowrey, P. A., Ward, E. S., & Wraith, D. C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.193.1.1 · Cited by 164
Carbone, F. R., Belz, G. T., & Heath, W. R. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.013 · Cited by 160
Schaft, N., Dörrie, J., Thumann, P., Beck, V. E., Müller, I., Schultz, E. S., Kämpgen, E., Dieckmann, D., & Schuler, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.3087 · Cited by 149
Lapenta, C., Santini, S. M., Spada, M., Donati, S., Urbani, F., Accapezzato, D., Franceschini, D., Andreotti, M., Barnaba, V., & Belardelli, F. (2006) · European Journal of Immunology · doi:10.1002/eji.200535579 · Cited by 147
Clinical applications of dendritic cell vaccination in the treatment of cancer
Cranmer, L. D., Trevor, K. T., & Hersh, E. M. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0432-5 · Cited by 142
Xu, S., Koski, G. K., Faries, M. B., Bedrosian, I., Mick, R., Maeurer, M. J., Cheever, M. A., Cohen, P. A., & Czerniecki, B. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2251 · Cited by 138
Migration of dendritic cell based cancer vaccines: in vivo veritas?
Adema, G. J., de Vries, I. J. M., Punt, C. J., & Figdor, C. G. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.01.004 · Cited by 134
Dannull, J., Nair, S. K., Su, Z. Z., Boczkowski, D., DeBeck, C., Yang, B. K., Gilboa, E., & Vieweg, J. (2004) · Blood · doi:10.1182/blood-2004-10-3944 · Cited by 133
Self-citationFay, J. W., Palucka, K., Paczesny, S., Dhodapkar, M. V., Johnston, D. A., Burkeholder, S. B., Ueno, H., & Banchereau, J. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0106-6 · Cited by 123
Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells
Wang, R., & Wang, H. Y. (2002) · Nature Biotechnology · doi:10.1038/nbt0202-149 · Cited by 122
Bullock, T. N. J., Mullins, D. W., & Engelhard, V. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.1822 · Cited by 112
Vambutas, A., DeVoti, J. A., Nouri, M., Drijfhout, J. W., Lipford, G. B., Bonagura, V. R., van der Burg, S. H., & Melief, C. J. M. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.049 · Cited by 110
Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes
Grünebach, F., Müller, M. R., Nencioni, A., & Brossart, P. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301901 · Cited by 103
Kim, T. W., Lee, J.-H., He, L., Boyd, D. A. K., Hardwick, J. M., Hung, C., & Wu, T.-C. (2005) · Cancer Research · doi:10.1158/0008-5472.309.65.1 · Cited by 98
Valmori, D., Dutoit, V., Schnüriger, V., Quiquerez, A., Pittet, M. J., Guillaume, P., Rubio‐Godoy, V., Walker, P. R., Rimoldi, D., Líénard, D., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.4231 · Cited by 92
Ma, M., Lyerly, H. K., Gilboa, E., Thomas, E. K., & Sk, N. (1998) · PubMed · Cited by 89
Self-citationBachmann, M. F., Beerli, R. R., Agnellini, P., Wolint, P., Schwarz, K., & Oxenius, A. (2006) · European Journal of Immunology · doi:10.1002/eji.200535730 · Cited by 89
Differing Roles of Inflammation and Antigen in T Cell Proliferation and Memory Generation
Busch, D. H., Kerksiek, K. M., & Pamer, E. G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4063 · Cited by 83
Ludewig, B., McCoy, K. D., Pericin, M., Ochsenbein, A. F., Dumrese, T., Odermatt, B., Toes, R. E. M., Melief, C. J. M., Hengartner, H., & Zinkernagel, R. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3678 · Cited by 81
Hanks, B. A., Jiang, J., Singh, R. A. K., Song, W., Barry, M. A., Huls, M. H., Slawin, K. M., & Spencer, D. M. (2005) · Nature Medicine · doi:10.1038/nm1183 · Cited by 81
Targeting plasmid‐encoded proteins to the antigen presentation pathways
Leifert, J. A., Rodriguez‐Carreno, M. P., Rodrı́guez, F., & Whitton, J. L. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.0135.x · Cited by 76
Dendritic cells under the spell of prostaglandins
Morelli, A. E., & Thomson, A. W. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00023-1 · Cited by 65
Direct stimulation of T cells by membrane vesicles from antigen-presenting cells
Kovář, M., Boyman, O., Shen, X., Hwang, I., Kohler, R. E., & Sprent, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603466103 · Cited by 61
Lesterhuis, W. J., de Vries, I. J. M., Adema, G. J., & Punt, C. J. A. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh919 · Cited by 60
Immune regulation in tumor-bearing hosts
Baecher‐Allan, C., & Anderson, D. E. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.01.010 · Cited by 49
B lymphocytes as antigen‐presenting cell‐based genetic vaccines
Zanetti, M., Castiglioni, P., Rizzi, M., Wheeler, M., & Gerloni, M. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00152.x · Cited by 36
Heiser, A., Coleman, D., Dannull, J., Yancey, D. R., Maurice, M. A., Lallas, C. D., Dahm, P., Niedzwiecki, D., Gilboa, E., & Vieweg, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214364 · Cited by 33
Self-citationTherapeutic dendritic-cell vaccine for simian AIDS
Lü, Wu, XX, X., et al. (2005) · 中国生物学文摘 · Cited by 28
Knocking the SOCS1 off dendritic cells
Gilboa, E. (2004) · Nature Biotechnology · doi:10.1038/nbt1204-1521 · Cited by 9
Self-citation
Cited by
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Immune evasion in cancer: mechanistic basis and therapeutic strategies
Vinay, D. S., Ryan, E. P., Pawelec, G., Talib, W. H., Stagg, J., Elkord, E., Lichtor, T., Decker, W. K., Whelan, R. L., Kumara, H. M. C. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.004 · Cited by 1,625
Biological applications of magnetic nanoparticles
Colombo, M., Carregal-Romero, S., Casula, M. F., Gutiérrez, L., Morales, M. P., Böhm, I. B., Heverhagen, J. T., Prosperi, D., & Parak, W. J. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15337h · Cited by 1,315
Hodi, F. S., Butler, M., Oble, D. A., Seiden, M. V., Haluska, F. G., Kruse, A., MacRae, S., Nelson, M., Canning, C., Lowy, I., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712237105 · Cited by 650
Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines
Melief, C. J. M., & van der Burg, S. H. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2373 · Cited by 594
Metadata
- Authors
- Gilboa, E.
- Venue
- Journal of Clinical Investigation
- Published
- 2007-05-01
- Volume
- 117
- Issue
- 5
- Pages
- 1195-1203
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2004911979
- Cited by
- 588
- References
- 106
- FWCI
- 21.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.